SLC3A2 and B-cell chronic lymphocytic leukemia: Clinical outcome of CLL is influenced by many factors, and the mutation status of immunoglobulin heavy chain variable region (IGHV), reflecting the differentiation stage of the B cell clone that eventually gives rise to CLL, is a strong prognostic factor (3, 4).